Checkpoint inhibitors in patients with advanced, refractory biliary tract cancers

被引：0
|
作者：
Liddell, S. [1 ]
Wintheiser, G. [1 ]
Jin, Z. [1 ]
Tran, N. [1 ]
Mahipal, A. [1 ]
机构：
[1] Mayo Clin, Rochester, MN USA
来源：
ANNALS OF ONCOLOGY | 2021年 / 32卷
关键词：
D O I：
10.1016/j.annonc.2021.05.332
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-278
引用
收藏
页码：S192 / S192
页数：1
相关论文
共 50 条
  • [1] mTOR Inhibitors in Advanced Biliary Tract Cancers
    Wu, Chao-En
    Chen, Ming-Huang
    Yeh, Chun-Nan
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (03)
  • [2] Immune Checkpoint Inhibitors for Advanced Biliary Tract Cancer
    Taghizadeh, Hossein
    Prager, Gerald W.
    CURRENT CANCER DRUG TARGETS, 2022, 22 (08) : 639 - 650
  • [3] Efficacy and safety of trametinib in Japanese patients with advanced biliary tract cancers refractory to gemcitabine
    Ikeda, Masafumi
    Ioka, Tatsuya
    Fukutomi, Akira
    Morizane, Chigusa
    Kasuga, Akiyoshi
    Takahashi, Hideaki
    Todaka, Akiko
    Okusaka, Takuji
    Creasy, Caretha L.
    Gorman, Shelby
    Felitsky, Daniel J.
    Kobayashi, Mikiro
    Zhang, Fanghong
    Furuse, Junji
    CANCER SCIENCE, 2018, 109 (01): : 215 - 224
  • [4] A phase II study of nivolumab in patients with advanced refractory biliary tract cancers (BTC).
    Kim, Richard D.
    Kim, Dae Won
    Alese, Olatunji B.
    Li, Daneng
    Shah, Neal
    Schell, Michael J.
    Zhou, Jun Min
    Chung, Vincent
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [5] The efficiency and safety of immune checkpoint inhibitors for advanced biliary tract cancers based on gene profiles: A retrospectively controlled study
    Yao, G. L.
    Fan, Y. G.
    MEDICINE, 2022, 101 (37) : E30443
  • [6] A Phase II multi institutional study of nivolumab in patients with advanced refractory biliary tract cancers (BTC)
    Kim, R.
    Kim, D.
    Alese, O.
    Li, D.
    El-Rayes, B.
    Shah, N.
    Schell, M.
    Zhou, J.
    Chung, V.
    ANNALS OF ONCOLOGY, 2018, 29
  • [7] The Efficacy of Immune Checkpoint Inhibitors in Advanced Biliary Tract Cancer with KRAS Mutation
    Jeong, Sun Young
    Jang, Jaeyeon
    Jeon, Youngkyung
    Jung, Ye Ji
    Choi, Daeho
    Hong, Joohyun
    Kim, Seung Tae
    Hong, Jung Yong
    Park, Joon Oh
    Park, Young Suk
    Lim, Ho Yeong
    CANCER RESEARCH, 2023, 83 (07)
  • [8] Clinical characteristics of liver injury induced by immune checkpoint inhibitors in patients with advanced biliary tract carcinoma
    Zhao Gao
    Shikai Wu
    Yinmo Yang
    Mingxia Sun
    Xiaodong Tian
    Xuan Jin
    Investigational New Drugs, 2023, 41 : 719 - 726
  • [9] Clinical characteristics of liver injury induced by immune checkpoint inhibitors in patients with advanced biliary tract carcinoma
    Gao, Zhao
    Wu, Shikai
    Yang, Yinmo
    Sun, Mingxia
    Tian, Xiaodong
    Jin, Xuan
    INVESTIGATIONAL NEW DRUGS, 2023, 41 (05) : 719 - 726
  • [10] Gemcitabine in advanced biliary tract cancers
    Pasetto, Lara Maria
    Andrea, Mario Rosario D'
    Falci, Cristina
    Monfardini, Silvio
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2007, 61 (03) : 230 - 242
12345